New Search

Export article

Graphite Bio: gene editing blood stem cells for sickle cell disease

Michael Eisenstein
Published: 7 July 2021

Abstract: Ex vivo gene editing of hematopoietic stem cells using CRISPR–Cas9 and adeno-associated virus serotype 6 is ready for trials in people with sickle-cell disease. Ex vivo gene editing of hematopoietic stem cells using CRISPR–Cas9 and adeno-associated virus serotype 6 is ready for trials in people with sickle-cell disease.
Keywords: hematopoietic / virus / gene editing / Bio / Graphite / sickle cell disease / Cas9

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

Share this article

Click here to see the statistics on "Nature Biotechnology" .
Back to Top Top